
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Barak Mizrahi, Tamar Sudry, Natalie Flaks‐Manov, et al.
BMJ (2023), pp. e072529-e072529
Open Access | Times Cited: 290
Barak Mizrahi, Tamar Sudry, Natalie Flaks‐Manov, et al.
BMJ (2023), pp. e072529-e072529
Open Access | Times Cited: 290
Showing 1-25 of 290 citing articles:
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, et al.
JAMA (2023) Vol. 329, Iss. 22, pp. 1934-1934
Open Access | Times Cited: 548
Tanayott Thaweethai, Sarah E. Jolley, Elizabeth W. Karlson, et al.
JAMA (2023) Vol. 329, Iss. 22, pp. 1934-1934
Open Access | Times Cited: 548
The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 261
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 261
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 109
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 109
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2905-2914
Open Access | Times Cited: 77
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2905-2914
Open Access | Times Cited: 77
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome
Artur Fedorowski, Richard Sutton
Nature Reviews Cardiology (2023) Vol. 20, Iss. 5, pp. 281-282
Open Access | Times Cited: 55
Artur Fedorowski, Richard Sutton
Nature Reviews Cardiology (2023) Vol. 20, Iss. 5, pp. 281-282
Open Access | Times Cited: 55
Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden
Artur Fedorowski, Alessandra Fanciulli, Satish R. Raj, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 379-395
Closed Access | Times Cited: 55
Artur Fedorowski, Alessandra Fanciulli, Satish R. Raj, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 379-395
Closed Access | Times Cited: 55
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study
Adela Alcolea-Medina, Luke B. Snell, Christopher Alder, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 887-890
Open Access | Times Cited: 51
Adela Alcolea-Medina, Luke B. Snell, Christopher Alder, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 887-890
Open Access | Times Cited: 51
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 51
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 51
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19
Min Seo Kim, Hayeon Lee, Seung Won Lee, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 3, pp. 291-302
Closed Access | Times Cited: 47
Min Seo Kim, Hayeon Lee, Seung Won Lee, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 3, pp. 291-302
Closed Access | Times Cited: 47
Understanding How Post–COVID-19 Condition Affects Adults and Health Care Systems
Gabrielle M. Katz, Katie Bach, Pavlos Bobos, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 7, pp. e231933-e231933
Open Access | Times Cited: 46
Gabrielle M. Katz, Katie Bach, Pavlos Bobos, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 7, pp. e231933-e231933
Open Access | Times Cited: 46
How methodological pitfalls have created widespread misunderstanding about long COVID
Tracy Beth Høeg, Shamez Ladhani, Vinay Prasad
BMJ evidence-based medicine (2023) Vol. 29, Iss. 3, pp. 142-146
Open Access | Times Cited: 42
Tracy Beth Høeg, Shamez Ladhani, Vinay Prasad
BMJ evidence-based medicine (2023) Vol. 29, Iss. 3, pp. 142-146
Open Access | Times Cited: 42
Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan
Sun Young Kim, Hayeon Lee, Jinseok Lee, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 8, pp. 1530-1544
Closed Access | Times Cited: 34
Sun Young Kim, Hayeon Lee, Jinseok Lee, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 8, pp. 1530-1544
Closed Access | Times Cited: 34
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Vaccine Effectiveness Against Long COVID in Children
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 29
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 29
Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study
Tim J. Hartung, Thomas Bahmer, Irina Chaplinskaya-Sobol, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102456-102456
Open Access | Times Cited: 28
Tim J. Hartung, Thomas Bahmer, Irina Chaplinskaya-Sobol, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102456-102456
Open Access | Times Cited: 28
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review
Jingyan Yang, Kristen Markus, Kathleen M. Andersen, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e077886-e077886
Open Access | Times Cited: 23
Jingyan Yang, Kristen Markus, Kathleen M. Andersen, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e077886-e077886
Open Access | Times Cited: 23
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 18
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 18
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors
Xiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
EBioMedicine (2023) Vol. 98, pp. 104851-104851
Open Access | Times Cited: 38
Xiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
EBioMedicine (2023) Vol. 98, pp. 104851-104851
Open Access | Times Cited: 38
Genome-wide Association Study of Long COVID
Vilma Lammi, Tomoko Nakanishi, Samuel E. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Vilma Lammi, Tomoko Nakanishi, Samuel E. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 32
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 32
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
Leora I. Horwitz, Tanayott Thaweethai, Shari B. Brosnahan, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286297-e0286297
Open Access | Times Cited: 27
Leora I. Horwitz, Tanayott Thaweethai, Shari B. Brosnahan, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286297-e0286297
Open Access | Times Cited: 27
Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study
Giulia Vivaldi, Paul Pfeffer, Mohammad Talaei, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102251-102251
Open Access | Times Cited: 27
Giulia Vivaldi, Paul Pfeffer, Mohammad Talaei, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102251-102251
Open Access | Times Cited: 27
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23